Liang Jin Selected Research

Anti-Bacterial Agents (Antibiotics)

1/2024	Chlorogenic acid inhibits macrophage PANoptosis induced by cefotaxime-resistant Escherichia coli.
8/2023	Gut Microbiota Metabolites Mediate Bax to Reduce Neuronal Apoptosis via cGAS/STING Axis in Epilepsy.
4/2023	Glycyrrhetinic acid prevents carbapenem-resistant Klebsiella pneumoniae-induced cell injury by inhibiting mitochondrial dysfunction via Nrf-2 pathway.
2/2011	Impact of p-glycoprotein inhibition and lipopolysaccharide administration on blood-brain barrier transport of colistin in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liang Jin Research Topics

Disease

55	Neoplasms (Cancer) 02/2024 - 10/2004
35	Breast Neoplasms (Breast Cancer) 02/2024 - 02/2009
24	Inflammation (Inflammations) 04/2024 - 02/2011
16	Neoplasm Metastasis (Metastasis) 05/2023 - 05/2012
16	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2021 - 01/2008
13	Infections 01/2024 - 07/2012
10	Carcinoma (Carcinomatosis) 08/2023 - 10/2004
10	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 04/2012
10	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 12/2011
9	Autoimmune Diseases (Autoimmune Disease) 02/2023 - 01/2009
9	Body Weight (Weight, Body) 01/2023 - 10/2009
8	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 01/2019
8	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 01/2016
7	Obesity 04/2024 - 12/2017
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 01/2018
6	Insulin Resistance 01/2022 - 12/2017
6	Hyperglycemia 11/2021 - 01/2014
5	Carcinogenesis 01/2022 - 01/2014
4	Wounds and Injuries (Trauma) 01/2024 - 12/2022
4	Fibrosis (Cirrhosis) 10/2023 - 12/2017
4	Melanoma (Melanoma, Malignant) 02/2023 - 07/2009
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2019
4	Necrosis 01/2022 - 05/2015
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 02/2015
4	Lung Neoplasms (Lung Cancer) 06/2019 - 01/2017
4	Atherosclerosis 10/2018 - 06/2009
3	Hypertension (High Blood Pressure) 04/2024 - 12/2017
3	Diabetic Nephropathies (Diabetic Nephropathy) 04/2024 - 07/2008
3	Pneumonia (Pneumonitis) 03/2024 - 01/2022
3	Hypoxia (Hypoxemia) 01/2022 - 09/2018
3	Adenocarcinoma 01/2022 - 01/2019
3	Hyperplasia 11/2019 - 01/2016
3	Bullous Pemphigoid (Pemphigoid) 01/2018 - 01/2013
3	Insulinoma 10/2017 - 06/2016
2	Cardiotoxicity 02/2024 - 10/2006
2	Bacterial Infections (Bacterial Infection) 01/2024 - 10/2012

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2004
19	Peptides (Polypeptides)IBA 01/2023 - 01/2008
13	Long Noncoding RNAIBA 10/2023 - 06/2018
11	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2017
10	CytokinesIBA 04/2024 - 12/2011
10	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2018
9	VaccinesIBA 12/2023 - 01/2008
9	Insulin (Novolin)FDA Link 11/2021 - 01/2014
8	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2010
7	Interleukin-6 (Interleukin 6)IBA 01/2023 - 10/2012
6	LipidsIBA 01/2024 - 06/2009
6	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 02/2009
6	LipopolysaccharidesIBA 01/2023 - 02/2011
6	AntibodiesIBA 10/2022 - 07/2009
6	Streptozocin (Streptozotocin)FDA Link 11/2021 - 05/2015
6	Estrogen ReceptorsIBA 01/2020 - 02/2009
6	EpitopesIBA 10/2017 - 04/2008
6	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2016 - 04/2008
5	AutoantibodiesIBA 10/2018 - 09/2009
4	Epidermal Growth Factor (EGF)IBA 02/2024 - 01/2017
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 02/2011
4	AntigensIBA 01/2023 - 06/2011
4	CateninsIBA 01/2022 - 11/2015
4	ErbB Receptors (EGF Receptor)IBA 01/2022 - 05/2012
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 10/2006
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2014
4	AutoantigensIBA 01/2017 - 01/2009
3	Blood Glucose (Blood Sugar)IBA 04/2024 - 01/2020
3	Carbapenems (Carbapenem Antibiotics)IBA 03/2024 - 04/2023
3	Circular RNAIBA 02/2024 - 01/2019
3	Amyloid (Amyloid Fibrils)IBA 11/2023 - 01/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023 - 01/2019
3	CollagenIBA 04/2023 - 07/2008
3	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2023 - 01/2016
3	ElementsIBA 01/2022 - 10/2004
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 12/2011
3	Interleukin-22 (IL-22)IBA 01/2022 - 01/2012
3	Small Interfering RNA (siRNA)IBA 01/2022 - 06/2016
3	Messenger RNA (mRNA)IBA 01/2022 - 08/2020
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 01/2017
3	Tamoxifen FDA LinkGeneric 11/2020 - 05/2012
3	PolymersIBA 11/2019 - 01/2017
3	Protein Kinases (Protein Kinase)IBA 10/2019 - 01/2018
3	FlavonoidsIBA 03/2019 - 03/2011
3	Hormones (Hormone)IBA 01/2019 - 12/2009
3	Keratin-17 (Keratin 17)IBA 12/2018 - 03/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 04/2012
3	CholesterolIBA 10/2018 - 06/2009
3	Chaperonin 60IBA 10/2017 - 06/2016
3	Colistin (Coly-Mycin)FDA Link 10/2012 - 10/2009
3	Progesterone Receptors (Progesterone Receptor)IBA 05/2012 - 02/2009
3	Gastrin-Releasing PeptideIBA 12/2009 - 07/2009
3	DNA VaccinesIBA 12/2009 - 07/2009
2	AnthracyclinesIBA 02/2024 - 01/2022
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 07/2021

Therapy/Procedure

35	Therapeutics 04/2024 - 03/2011
12	Drug Therapy (Chemotherapy) 01/2024 - 06/2011
10	Immunotherapy 01/2022 - 01/2009
6	Neoadjuvant Therapy 02/2024 - 12/2011
6	Segmental Mastectomy (Lumpectomy) 02/2024 - 12/2011
5	Radiotherapy 01/2022 - 01/2014
3	Esophagectomy 04/2020 - 01/2018
3	Glycemic Control 01/2018 - 02/2015